This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Klara Totpal: Innovator in Antibody Drug Conjugates
Introduction
Klara Totpal is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments using bispecific antibodies. Her work is instrumental in advancing therapeutic options for patients.
Latest Patents
Klara holds a patent titled "Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates." This patent reflects her expertise in creating targeted therapies that enhance the efficacy of cancer treatments.
Career Highlights
Klara is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her role at Genentech allows her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Throughout her career, Klara has worked alongside talented colleagues, including Brendan Christian Bender and Stephen James Simko. These collaborations have fostered an environment of innovation and creativity, leading to advancements in therapeutic strategies.
Conclusion
Klara Totpal's contributions to the field of biotechnology and her innovative patent work exemplify her commitment to improving patient outcomes. Her career at Genentech highlights her role as a key player in the development of cutting-edge therapies.